Author

Megan LaCroix

Medical College of Wisconsin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Allison D. EbertiD· 1 shared Barrington G. BurnettiD· 1 shared Brendan M. Melvin· 1 shared Cecelia C Mangione· 1 shared Jessica E. Gawrys· 1 shared Matthew M. HarmelinkiD· 1 shared Mya Suneja· 1 shared Natalya Belous· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Allison D. EbertORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

IL-1Ra and CCL5, but not IL-10, are promising targets for treating SMA astrocyte-driven pathology

Reilly L. Allison, Cecelia C Mangione, Mya Suneja, Jessica E. Gawrys, Brendan M. Melvin, Natalya Belous, Megan LaCroix, Matthew M. Harmelink, Barrington G. Burnett, Allison D. Ebert

This study identifies IL-1ra and CCL5 as potential therapeutic targets for SMA by showing they reduce astrocyte-driven inflammation and improve disease outcomes in vitro and in mice.

Molecular Therapy · Dec 12, 2024Peer-reviewedNeuroscience